أعرض في EDS

Supplementary Table from Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing

التفاصيل البيبلوغرافية
العنوان:	Supplementary Table from Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing
المؤلفون:	Kimberly L. Blackwell, Sarah Bacus, Renee A. Welch, Erika Hamilton, Justin Favaro, Gretchen G. Kimmick, Judith Hopkins, P. Kelly Marcom, Bercedis L. Peterson, Vijaya Chadaram, Christina I. Herold
بيانات النشر:	American Association for Cancer Research (AACR), 2023.
سنة النشر:	2023
الوصف:	XLS file - 16K, Pulmonary and pleural effusions, pneumonitis.
DOI:	10.1158/1078-0432.22444086
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5bf3beb80e1a37fabde4ae5b4ab567b https://doi.org/10.1158/1078-0432.22444086
Rights:	OPEN
رقم الانضمام:	edsair.doi.dedup.....b5bf3beb80e1a37fabde4ae5b4ab567b
قاعدة البيانات:	OpenAIRE

الوصف
DOI:	10.1158/1078-0432.22444086